Skip to main content
Caplight Logo









Vital Bio

Vital Bio

Private
TorontoHealthcare & Life Scienceshttps://vitalbio.com/

Last Round

Series A

Jul 24, 2023

Total Funding Raised

$77.44M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vital Bio is a healthcare technology company that develops advanced diagnostic solutions, including the VitalOne point-of-care platform, to enhance the personalization, accessibility, and effectiveness of medical care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Healthcare Analytics, Health IoT

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

point-of-care diagnosticsPOC testingblood testing deviceclinical laboratorymedical devicemicrofluidicsdiagnostic platformautomated blood analysislab-on-a-chipclinical workflow integrationdiagnostic consumablescomputer vision diagnosticsdecentralized diagnosticsrapid blood testinghealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vital Bio Comparables

Compare Vital Bio with similar companies based on industry and business-model similarity.

Vital Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Truvian
89%
Chronus Health
83%
Instadiagnostics, Inc.
81%

Vital Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 24, 2023
SeedOct 1, 2019

Key People

Founding team and executive leadership

Vasu Nadella

Co-Founder, CEO

Founding Team

Vital Bio Investors

Notable investors and investment history

Vital Bio investors
InvestorRounds
Forefront Venture PartnersSeries A
Inovia CapitalSeries A, Early Funding, Seed
Stanford UniversitySeries A
BrightEdgeSeries A
Northpond VenturesSeries A
NEXT VENTŪRESSeries A
Route 66 VenturesSeries A, Early Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Transitioning from pre-revenue to active manufacturing and commercial production.

  • Jul 24, 2023

    $18.6M round led by Northpond Ventures and Leerink Transformation Partners.

Vital Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vital Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vital Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range265
Year Founded2019
Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?